About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- xylometazoline
- Procedure number
- PSUSA/00003134/202005
- Regulatory outcome
- Variation
Documents
Xylometazoline: List of nationally authorised medicinal products - PSUSA/00003134/202005
English (EN) (415.03 KB - PDF)
Xylometazoline: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00003134/202005
English (EN) (42.04 KB - PDF)
български (BG) (113.17 KB - PDF)
español (ES) (38.26 KB - PDF)
čeština (CS) (132.01 KB - PDF)
dansk (DA) (44.97 KB - PDF)
Deutsch (DE) (44.27 KB - PDF)
eesti keel (ET) (40.32 KB - PDF)
ελληνικά (EL) (107.29 KB - PDF)
français (FR) (38.16 KB - PDF)
hrvatski (HR) (104.92 KB - PDF)
íslenska (IS) (33.25 KB - PDF)
italiano (IT) (38.38 KB - PDF)
latviešu valoda (LV) (96.84 KB - PDF)
lietuvių kalba (LT) (103.3 KB - PDF)
magyar (HU) (106.63 KB - PDF)
Malti (MT) (103.29 KB - PDF)
Nederlands (NL) (31.83 KB - PDF)
norsk (NO) (37.75 KB - PDF)
polski (PL) (98.43 KB - PDF)
português (PT) (37.94 KB - PDF)
română (RO) (95.73 KB - PDF)
slovenčina (SK) (101 KB - PDF)
slovenščina (SL) (99.79 KB - PDF)
Suomi (FI) (42.64 KB - PDF)
svenska (SV) (37.57 KB - PDF)